Literature DB >> 16837010

Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.

Ying Wang1, Yuanyuan Xu, W Glenn L Kerrick, Yingcai Wang, Georgianna Guzman, Zoraida Diaz-Perez, Danuta Szczesna-Cordary.   

Abstract

Clinical studies have revealed that mutations in the ventricular myosin regulatory light chain (RLC) lead to the development of familial hypertrophic cardiomyopathy (FHC), an autosomal dominant disease characterized by left ventricular hypertrophy, myofibrillar disarray and sudden cardiac death. While mutations in other contractile proteins have been studied widely by others, there is no report elucidating the mechanism(s) associated with FHC-linked RLC mutations. In this study, we have assessed the functional consequences of two RLC mutations, R58Q and N47K, in transgenic mice. Clinical phenotypes associated with these mutations included inter-ventricular hypertrophy, abnormal ECG findings and the R58Q mutation caused multiple cases of premature sudden cardiac death. Simultaneous measurements of the ATPase and force in transgenic skinned papillary muscle fibers from mutated versus control mice showed an increase in the Ca(2+) sensitivity of ATPase and steady-state force only in R58Q fibers. The calculated energy cost or rate of dissociation of force generating myosin cross-bridges (ATPase/force ratio) plotted as a function of activation state was the same in all groups of fibers. Both mutations caused prolonged [Ca(2+)] transients in electrically stimulated intact papillary muscles; however, the R58Q mutation also resulted in a significantly prolonged force transient. Our results suggest that the phenotypes of FHC observed in patients harboring these RLC mutations correlate with the extent of physiological changes monitored in transgenic fibers. Cardiac hypertrophy observed in patients is most likely caused by the activation of compensatory mechanisms ensuing from higher workloads due to incomplete relaxation as evidenced by prolonged [Ca(2+)] transients for both N47K and R58Q fibers. Furthermore, the poor prognosis of the R58Q patients may be associated with more severe diastolic dysfunction due to the slower off-rate of Ca(2+) from troponin C leading to longer force and [Ca(2+)] transients and increased Ca(2+) sensitivity of ATPase and force.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837010     DOI: 10.1016/j.jmb.2006.06.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

1.  Cardiomyopathy-linked myosin regulatory light chain mutations disrupt myosin strain-dependent biochemistry.

Authors:  Michael J Greenberg; Katarzyna Kazmierczak; Danuta Szczesna-Cordary; Jeffrey R Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

Review 2.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

3.  Familial hypertrophic cardiomyopathy can be characterized by a specific pattern of orientation fluctuations of actin molecules .

Authors:  J Borejdo; D Szczesna-Cordary; P Muthu; N Calander
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

4.  Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.

Authors:  Wenrui Huang; Katarzyna Kazmierczak; Zhiqun Zhou; Vanessa Aguiar-Pulido; Giri Narasimhan; Danuta Szczesna-Cordary
Journal:  Arch Biochem Biophys       Date:  2016-02-22       Impact factor: 4.013

5.  Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.

Authors:  Priya Muthu; Li Wang; Chen-Ching Yuan; Katarzyna Kazmierczak; Wenrui Huang; Olga M Hernandez; Masataka Kawai; Thomas C Irving; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2011-09-01       Impact factor: 5.191

6.  Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions.

Authors:  D Duggal; J Nagwekar; R Rich; W Huang; K Midde; R Fudala; H Das; I Gryczynski; D Szczesna-Cordary; J Borejdo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-13       Impact factor: 4.733

Review 7.  Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.

Authors:  Wenrui Huang; Danuta Szczesna-Cordary
Journal:  J Muscle Res Cell Motil       Date:  2015-09-18       Impact factor: 2.698

Review 8.  Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.

Authors:  Sunil Yadav; Yoel H Sitbon; Katarzyna Kazmierczak; Danuta Szczesna-Cordary
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

9.  Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.

Authors:  W Glenn L Kerrick; Katarzyna Kazmierczak; Yuanyuan Xu; Yingcai Wang; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2008-11-05       Impact factor: 5.191

10.  Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.

Authors:  Wenrui Huang; Jingsheng Liang; Katarzyna Kazmierczak; Priya Muthu; Divya Duggal; Gerrie P Farman; Lars Sorensen; Iraklis Pozios; Theodore P Abraham; Jeffrey R Moore; Julian Borejdo; Danuta Szczesna-Cordary
Journal:  J Mol Cell Cardiol       Date:  2014-06-30       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.